SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016967
Filing Date
2023-05-15
Accepted
2023-05-15 09:00:52
Documents
33
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 292889
2 ex31-1.htm EX-31.1 11870
3 ex31-2.htm EX-31.2 11804
4 ex32-1.htm EX-32.1 5916
5 ex32-2.htm EX-32.2 6012
  Complete submission text file 0001493152-23-016967.txt   1568638

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inti-20230331.xsd EX-101.SCH 10596
7 XBRL CALCULATION FILE inti-20230331_cal.xml EX-101.CAL 20785
8 XBRL DEFINITION FILE inti-20230331_def.xml EX-101.DEF 47888
9 XBRL LABEL FILE inti-20230331_lab.xml EX-101.LAB 120932
10 XBRL PRESENTATION FILE inti-20230331_pre.xml EX-101.PRE 91280
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 102223
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 23918807
SIC: 2834 Pharmaceutical Preparations